Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
To establish the role of ketamine in hospitalized terminally ill cancer patients with
refractory cancer pain, using continuous intravenous infusion of ketamine